Edition:
India

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

12.29USD
22 Oct 2020
Change (% chg)

$0.00 (-0.00%)
Prev Close
$12.29
Open
$11.79
Day's High
$12.47
Day's Low
$11.79
Volume
338,968
Avg. Vol
506,863
52-wk High
$26.98
52-wk Low
$6.58

Select another date:

Fri, May 29 2020

BRIEF-Adverum Biotech Announces New Mid-Stage Trial For ADVM-022 In Diabetic Macular Edema

* ADVERUM BIOTECHNOLOGIES ANNOUNCES NEW INFINITY PHASE 2 TRIAL FOR ADVM-022 IN DIABETIC MACULAR EDEMA, REPORTS RECENT BUSINESS PROGRESS AND FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Adverum Biotech Reports Positive Interim Data From Cohorts 1-3 Of Optic Phase 1 Trial Of Advm-022 Intravitreal Gene Therapy For Wet AMD

* ADVERUM BIOTECHNOLOGIES REPORTS POSITIVE INTERIM DATA FROM COHORTS 1-3 OF OPTIC PHASE 1 TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD

BRIEF-Adverum Biotechnologies Doses First Patient In Cohort 4 Of OPTIC Phase 1 Clinical Trial Of ADVM-022

* ADVERUM BIOTECHNOLOGIES DOSES FIRST PATIENT IN COHORT 4 OF OPTIC PHASE 1 CLINICAL TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD Source text for Eikon: Further company coverage:

Select another date: